Alnylam Pharmaceuticals
ALNY
#582
Rank
NZ$60.49 B
Marketcap
$467.40
Share price
-1.34%
Change (1 day)
81.89%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company